ibutilide (Corvert)
Jump to navigation
Jump to search
Introduction
Tradename: Corvert. (ibutilide fumarate) Presumptive Group 1c anti-arrhythmic agent.
Indications
- cardioversion of acute atrial fibrillation/flutter of recent onset
Dosage
- 0.01 mg/kg up to 1 mg IV over 10 minutes
- may repeat if no response in 10 minutes Injection (fumarate): 0.1 mg/mL (10 mL).
Pharmacokinetics
- onset of action:
- within 90 minutes after start of infusion
- 1/2 of conversions occur during infusion
- extensively metabolized in the liver
- elimination 1/2life 2-12 hours
- parent drug & metabolite eliminated in urine
elimination via liver
elimination via kidney
1/2life = 2-12 hours
Monitor
- continuous EKG for at least 4 hours following infusion until QTc has returned to baseline
- electrolytes (including Mg+2 & K+) should be corrected prior to administration
Adverse effects
- less common (1-10%)
- QT prolongation (Torsades de pointes in 2-8%)
- non-sustained monomorphic & polymorphic ventricular tachycardia
- non-sustained monomorphic ventricular extrasystoles
- supraventricular tachycardia
- hypotension
- bundle-branch block
- AV block
- bradycardia
- hypertension
- palpitations
- headache
- nausea
- uncommon (< 1%)
Drug interactions
- prolonged refractoriness with:
- class Ia anti-arrhythmic agents
- other class III anti-arrhythmic agents
- risk of excessive QT interval prolongation with:
- phenothiazines
- tricyclic antidepressants (TCA)
- cisapride
- non-sedating antihistamines: astemizole & terfenadine
- masking of signs of digoxin toxicity
More general terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ Mountantonakis SE, Moutzouris DA, Tiu RV, Papaioannou GN, McPherson CA. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter. Am J Emerg Med. 2006 Jul;24(4):407-12. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16787796
Database
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=60752
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=60753
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5281065
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=107872
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3025729